Christopher Perry, DO
Otolaryngology · Toledo, OHNPI 1457353104
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 486 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,614, 2.6 times the $1,025 reported in 2019. Among otolaryngology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 486 payments — averaging $22.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$2K
- Sanofi$1K
- AbbVie$1K
- Acclarent, Inc$1K
- GSK$891
- Aerin Medical Inc.$832
- plus $4K from 22 others
What the payments were for
- Consulting fees$751%
- Food & beverage$10,49497%
- Education$2122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 62 | $1,572 |
| Sanofi | 40 | $1,362 |
| AbbVie | 130 | $1,217 |
| Acclarent, Inc | 29 | $1,160 |
| GSK | 37 | $891 |
| Aerin Medical Inc. | 37 | $832 |
| Regeneron Healthcare Solutions, Inc. | 45 | $660 |
| Pfizer | 26 | $471 |
| Intersect ENT, Inc. | 10 | $408 |
| Medtronic | 3 | $217 |
| Biohaven Pharmaceuticals, Inc. | 4 | $214 |
| AstraZeneca | 8 | $196 |
| Phathom Pharmaceuticals, Inc. | 7 | $196 |
| Amgen | 5 | $183 |
| Sanofi-aventis U.S. LLC | 3 | $178 |
| Vertex | 4 | $170 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $153 |
| Stryker | 3 | $136 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Cochlear Americas | 1 | $109 |
| Smith+Nephew | 5 | $81 |
| Alk-abello, Inc | 4 | $71 |
| Phadia US Inc. | 3 | $52 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
| Fortovia Therapeutics, Inc. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Integra Lifesciences Corporation | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$714
- DUPIXENT$501
- UBRELVY$333
- VIVAER STYLUS$324
- RHINAER STYLUS$324
- Acclarent Navwire$274
- NUCALA$250
- PROPEL$133
- QULIPTA$125
- Symbravo$125
- ZAVZPRET$121
- JOURNAVX$119
- Relieva Ultirra$117
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$109
- Baha$109
- OSIA OSI300 IMPLANT$109
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$104
- TruDi Navigation System$102
- AIMOVIG$102
How this compares
$10,781 in reported general payments places this provider in the 90th percentile of 380 otolaryngology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $72,032 |
| Dupixent SyringeDupilumab | 13 | $49,857 |
| Ipratropium Bromide | 145 | $3,927 |
| Famotidine | 357 | $3,227 |
| Azelastine Hcl | 66 | $1,580 |
| Omeprazole | 143 | $1,324 |
| Fluticasone Propionate | 129 | $1,056 |
| Pantoprazole Sodium | 51 | $775 |
| Doxycycline Hyclate | 68 | $475 |
| Montelukast Sodium | 21 | $243 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $146 |
| Prednisone | 72 | $103 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $91 |
| Mupirocin | 18 | $88 |
| Levofloxacin | 14 | $83 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Toledo
- Vincent TomaToledo$9K
- Afser ShariffToledo$4K
- Raj SindwaniCleveland$598K
- Mark MehleCleveland$403K
- Troy WoodardCleveland$392K
- Oliver AdunkaColumbus$338K
- Subinoy DasColumbus$142K
- Sanjeet RangarajanCleveland$113K
- Sumit BapnaDublin$95K
- Boris KaranfilovDublin$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.